|
業務類別
|
-- |
|
業務概覽
|
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADCplatform. |
| 公司地址
| 1825 S. Grant Street, San Mateo, CA, USA, 94402 |
| 電話號碼
| +1 650 800-6676 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.vincerx.com |
| 員工數量
| 13 |
| Dr. Raquel E. Izumi, PhD |
Director and Acting Chief Executive Officer |
-- |
27/03/2025 |
| Mr. Kevin Haas |
Acting Chief Financial Officer |
-- |
27/03/2025 |
|
|
| Dr. Brian J. Druker, M.D. |
Independent Director |
27/03/2025 |
| Dr. Raquel E. Izumi, PhD |
Director and Acting Chief Executive Officer |
27/03/2025 |
| Mr. Francisco D. Salva |
Independent Director |
27/03/2025 |
| Dr. Laura I. Bushnell, PhD |
Independent Director |
27/03/2025 |
| Mr. Ruth E. Stevens |
Independent Director |
27/03/2025 |
| Dr. John H. Lee, M.D. |
Independent Director |
27/03/2025 |
| Dr. Ahmed M. Hamdy, M.D. |
Chairman of the Board |
27/03/2025 |
|
|
|
|
